ARCHIVES

The Impact of Triple Calamities: Flat Funding, the End of ARRA, and a Dramatic Loss of Purchasing Power

This article is from The Cancer Letter archive.

Vol. 40 No. 41 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

NCI appoints Robert Young chairman of the Board of Scientific Advisors, reappoints Ellen Sigal, and names 11 new members to board. Earnest Hawk to direct NCI Office of Centers, Training and Resources.

November 12, 2004

FDA Clears Avastin-Interferon Combination In Renal Cancer; Interferon Role Undefined.

August 7, 2009

Study Tracks Lifestyle Factors For Cancer Burden In Blacks

October 26, 2001

In Brief: NBCC Wins Grants To Train Breast Cancer Activists In Language, Concepts Of Science

January 13, 1995

ASCO President Criticizes Use Of Cooperative Agreement in Clinical Trials

May 18, 1984

Reviewers Report Progress In New Drug Prescreen System Development, Commend DTP

December 15, 1989